Intellia Therapeutics, Inc. (NTLA)
13.67
+0.58
(+4.43%)
USD |
NASDAQ |
May 15, 16:00
13.50
-0.17
(-1.24%)
After-Hours: 20:00
Intellia Therapeutics Shareholders Equity (Quarterly) : 620.94M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.025B |
| KalVista Pharmaceuticals, Inc. | -19.65M |
| Beam Therapeutics, Inc. | 1.164B |
| Novavax, Inc. | -144.76M |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 758.78M |
| Total Liabilities (Quarterly) | 137.84M |
| Debt to Equity Ratio | 0.1296 |
| Current Ratio | 6.102 |
| Net Debt Paydown Yield | 1.68% |